Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Gil-Villalba

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Medicina Clinica|July 7, 2021
[Perniosis-like lesions after vaccination with mRNA against COVID-19]Israel Pérez-López, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
Medicina Clinica (English Ed.)|January 26, 2022
Perniosis-like lesions after vaccination with mRNA against COVID-19Israel Pérez-López, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
European Journal of Dermatology : EJD|July 31, 2025
sQUIZ your knowledge! A subcutaneous nodule with a fatal evolutionMarta Cebolla-Verdugo, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
Revista Espanola De Geriatria Y Gerontologia|December 17, 2024
[Prostate adenocarcinoma cutaneous metastasis]María Zulaika-Lloret, Ana Gil-Villalba, Marta Cebolla-Verdugo, et al.
Life (Basel, Switzerland)|November 25, 2023
Laser Therapy for Vulvar Lichen Sclerosus, a Systematic ReviewAna Gil-Villalba, Angela Ayen-Rodriguez, Maria Jose Naranjo-Diaz, et al.
Dermatologic Therapy|August 17, 2022
Successful treatment of follicular mucinosis with low-dose UVA1 phototherapyAna Gil-Villalba, Francisco Javier de la Torre-Gomar, Francisco José Navarro-Triviño, et al.
Life (Basel, Switzerland)|January 8, 2025
Efficacy of Fractional CO<sub>2</sub> Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational StudyAna Gil-Villalba, Ángela Ayén-Rodríguez, María José Naranjo-Díaz, et al.
International Journal of Dermatology|July 1, 2022
Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workersRicardo Ruiz-Villaverde, Mario Rivera-Izquierdo, Ana Gil-Villalba, et al.
Vaccines|January 22, 2022
Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital WorkersMario Rivera-Izquierdo, Eva Soler-Iborte, Javier Pérez de Rojas, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medicina Clinica|July 7, 2021
[Perniosis-like lesions after vaccination with mRNA against COVID-19]Israel Pérez-López, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
Medicina Clinica (English Ed.)|January 26, 2022
Perniosis-like lesions after vaccination with mRNA against COVID-19Israel Pérez-López, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
European Journal of Dermatology : EJD|July 31, 2025
sQUIZ your knowledge! A subcutaneous nodule with a fatal evolutionMarta Cebolla-Verdugo, Ana Gil-Villalba, Ricardo Ruiz-Villaverde
Revista Espanola De Geriatria Y Gerontologia|December 17, 2024
[Prostate adenocarcinoma cutaneous metastasis]María Zulaika-Lloret, Ana Gil-Villalba, Marta Cebolla-Verdugo, et al.
Life (Basel, Switzerland)|November 25, 2023
Laser Therapy for Vulvar Lichen Sclerosus, a Systematic ReviewAna Gil-Villalba, Angela Ayen-Rodriguez, Maria Jose Naranjo-Diaz, et al.
Dermatologic Therapy|August 17, 2022
Successful treatment of follicular mucinosis with low-dose UVA1 phototherapyAna Gil-Villalba, Francisco Javier de la Torre-Gomar, Francisco José Navarro-Triviño, et al.
Life (Basel, Switzerland)|January 8, 2025
Efficacy of Fractional CO<sub>2</sub> Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational StudyAna Gil-Villalba, Ángela Ayén-Rodríguez, María José Naranjo-Díaz, et al.
International Journal of Dermatology|July 1, 2022
Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workersRicardo Ruiz-Villaverde, Mario Rivera-Izquierdo, Ana Gil-Villalba, et al.
Vaccines|January 22, 2022
Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital WorkersMario Rivera-Izquierdo, Eva Soler-Iborte, Javier Pérez de Rojas, et al.
Pageof 1